Magnetic Resonance-guided Laser-induced Thermal Therapy Research Articles

342 Long-Term Follow-up of 54 Cases of Recurrent Glioblastoma Treated with Magnetic Resonance-Guided Laser Interstitial Thermal Therapy

INTRODUCTION: Magnetic resonance guided laser-induced thermal therapy (MRgLITT) is a novel minimally invasive procedural treatment for progressive cerebral lesions and cerebral edema related to post-radiation treatment effect. METHODS: We conducted a single-center retrospective study of pre-operative imaging, clinical characteristics and survival outcomes of 54 patients with previously treated (WHO Grade IV) between January 2013 to December 2020. RESULTS: The average age of patients was 58.7 ± 12.0 years. Patients underwent MRgLITT a median time of 21.6 ± 23.7 months from original diagnosis. 20% (n = 11) of patients had previous history of stereotactic radiosurgery, 61% (n = 33) intensity-modulated radiation therapy, and 80% (n = 43) chemotherapy. There was an average of 1.2 ± 0.7 prior surgical resections before MRgLITT was performed. 41% (n = 22) of patients were on dexamethasone at the time of treatment. The median pre-operative enhancing lesion volume on T1 gadolinium-enhanced magnetic resonance imaging (MRI) was 9.7 cm3 (standard error [SE], 2.0 cm3) and 27.0 cm3 (SE, 5.6 cm3) on T2 fluid-attenuated inversion recovery MRI. The pathology of the biopsies taken during MRgLITT confirmed tumor recurrence in 61% (n = 33) of patients, and treatment effect or reactive changes in 37% (n = 20) of patients. 67% (n = 28) experienced radiographic evidence of progression of the previously treated lesion, while 21% (n =9) and 12% (n = 5) experienced progression of a new lesion or both, respectively. Progression-free survival after MRgLITT was 3.5 months (standard error [SE], 0.6; 95% CI, 2.4-4.6). At the time of the study, 78% (n = 42) of patients were deceased. Mean overall survival time was 29.9 months (SE, 4.3; 95% CI, 21.4-38.3). Mean survival time after MRgLITT was 8.3 months (SE, 1.2; 95% CI, 5.9-10.6. Of the 12 remaining living patients, 36% (n = 4) had a decline in their clinical status at the time of last follow up, while 64% (n = 7) and 9% (n = 1) were stable or improved, respectively. Patients were followed for a mean time interval of 9.25 ± 12.2 months from MRgLITT. CONCLUSION: MRgLITT may be a viable, minimally invasive option for patients with glioblastoma but is associated with relatively short post-treatment progression-free survival.

Potential surgical therapies for drug-resistant focal epilepsy.

Drug‐resistant focal epilepsy (DRFE), defined by failure of two antiepileptic drugs, affects 30% of epileptic patients. Epilepsy surgeries are alternative options for this population. Preoperative evaluation is critical to include potential candidates, and to choose the most appropriate procedure to maximize efficacy and simultaneously minimize side effects. Traditional procedures involve open skull surgeries and epileptic focus resection. Alternatively, neuromodulation surgeries use peripheral nerve or deep brain stimulation to reduce the activities of epileptogenic focus. With the advanced improvement of laser‐induced thermal therapy (LITT) technique and its utilization in neurosurgery, magnetic resonance‐guided LITT (MRgLITT) emerges as a minimal invasive approach for drug‐resistant focal epilepsy. In the present review, we first introduce drug‐resistant focal epilepsy and summarize the indications, pros and cons of traditional surgical procedures and neuromodulation procedures. And then, focusing on MRgLITT, we thoroughly discuss its history, its technical details, its safety issues, and current evidence on its clinical applications. A case report on MRgLITT is also included to illustrate the preoperational evaluation. We believe that MRgLITT is a promising approach in selected patients with drug‐resistant focal epilepsy, although large prospective studies are required to evaluate its efficacy and side effects, as well as to implement a standardized protocol for its application.

Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.

Intraoperative dynamics of magnetic resonance-guided laser-induced thermal therapy (MRgLITT) have been previously characterized for ablations of naive tissue. However, most treatment sessions require the delivery of multiple doses, and little is known about the ablation dynamics when additional doses are applied to heat-damaged tissue. This study investigated the differences in ablation dynamics between naive versus damaged tissue. The authors examined 168 ablations from 60 patients across various surgical indications. All ablations were performed using the Visualase MRI-guided laser ablation system (Medtronic), which employs a 980-nm diffusing tip diode laser. Cases with multiple topographically overlapping doses with constant power were selected for this study. Single-dose intraoperative thermal damage was used to calculate ablation rate based on the thermal damage estimate (TDE) of the maximum area of ablation achieved (TDEmax) and the total duration of ablation (tmax). We compared ablation rates of naive undamaged tissue and damaged tissue exposed to subsequent thermal doses following an initial ablation. TDEmax was significantly decreased in subsequent ablations compared to the preceding ablation (initial ablation 227.8 ± 17.7 mm2, second ablation 164.1 ± 21.5 mm2, third ablation 124.3 ± 11.2 mm2; p = < 0.001). The ablation rate of subsequent thermal doses delivered to previously damaged tissue was significantly decreased compared to the ablation rate of naive tissue (initial ablation 2.703 mm2/sec; second ablation 1.559 mm2/sec; third ablation 1.237 mm2/sec; fourth ablation 1.076 mm/sec; p = < 0.001). A negative correlation was found between TDEmax and percentage of overlap in a subsequent ablation with previously damaged tissue (r = -0.164; p < 0.02). Ablation of previously ablated tissue results in a reduced ablation rate and reduced TDEmax. Additionally, each successive thermal dose in a series of sequential ablations results in a decreased ablation rate relative to that of the preceding ablation. In the absence of a change in power, operators should anticipate a possible reduction in TDE when ablating partially damaged tissue for a similar amount of time compared to the preceding ablation.

Magnetic Resonance-Guided Laser-Induced Thermal Therapy for the Treatment of Progressive Enhancing Inflammatory Reactions Following Stereotactic Radiosurgery, or PEIRs, for Metastatic Brain Disease.

In patients who have previously undergone maximum radiation for metastatic brain tumors, a progressive enhancing inflammatory reaction (PEIR) that represents either tumor recurrence or radiation necrosis, or a combination of both, can occur. Magnetic resonance-guided laser-induced thermal therapy (LITT) offers a minimally invasive treatment option for this problem. To report our single-center experience using LITT to treat PEIRs after radiosurgery for brain metastases. Patients with progressive, enhancing reactions at the site of prior radiosurgery for metastatic brain tumors and who had a Karnofsky performance status of≥70 were eligible for LITT. The primary endpoint was local control. Secondary end points included dexamethasone use and procedure-related complications. Between 2010 and 2017, 59 patients who underwent 74 LITT procedures for 74 PEIRs met inclusion criteria. The mean pre-LITT PEIR size measured 3.4±0.4 cm3. At a median follow-up of 44.6 wk post-LITT, the local control rate was 83.1%. Most patients were weaned off steroids post-LITT. Patients experiencing a post-LITT complication were more likely to remain on steroids indefinitely. The rate of new permanent neurological deficit was 3.4%. LITT is an effective treatment for local control of PEIRs after radiosurgery for metastatic brain disease. When possible, we recommend offering LITT once PEIRs are identified and prior to the initiation of high-dose steroids for symptom relief.

Assessment of Optimal Imaging Protocol Sequences After Laser-Induced Thermal Therapy for Intracranial Tumors.

Magnetic resonance-guided laser-induced thermal therapy (MRgLITT) is a novel, minimally invasive method currently being used to treat a wide range of intracranial pathologies. No accepted guidelines exist on what the appropriate magnetic resonance imaging (MRI) sequences are for evaluating short-term postablation changes, especially when patients are not able to receive gadolinium. To evaluate which MRI sequences provide the greatest inter-rater reliability and least amount of variability in assessment of ablation volume after MRgLITT for intracranial neoplasms. Twenty patients who received MRgLITT were included. Three raters calculated volumetric measurements on postprocedural axial spoiled gradient recalled (SPGR), fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), and gradient echo (GRE) sequences. Measured volumes were analyzed using intraclass correlation to determine which protocol had the most concordance among the 3 raters. Postcontrast SPGR sequences were most concordant in our study, with an intraclass correlation of 0.981. DWI was the next-most concordant imaging sequence with an intraclass correlation of 0.958. The least concordant were GRE (0.895) and FLAIR (0.866) images. SPGR was also the least variable and had the most consistent volume ratings compared to the other sequences. This study is the first to evaluate the inter-rater reliability of different MRI sequence protocols in the context of post-MRgLITT volumetric evaluation. SPGR postcontrast images facilitate the greatest interobserver concordance when characterizing post-MRgLITT tumor appearance and volumetrics, with DWI ranked second. Based on our findings, SPGR sequences are likely to yield the highest degree of concordance in post-MRgLITT lesion evaluation. When gadolinium cannot be given, DWI should provide the next most reliable estimation.

302 Corticosteroid Use and Its Relation to Postoperative Edema in Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Metastatic Brain Tumors

302 Corticosteroid Use and Its Relation to Postoperative Edema in Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Metastatic Brain Tumors

Effects of variable power on tissue ablation dynamics during magnetic resonance-guided laser-induced thermal therapy with the Visualase system

Purpose: Magnetic resonance-guided laser-induced thermal therapy (MRgLITT) is a minimally invasive procedure used to treat various intracranial pathologies. This study investigated the effects of variable power on maximal estimated thermal damage during ablation and duration required to reach maximal ablation.Materials/Methods: All ablations were performed using the Visualase Thermal Therapy System (Medtronic Inc., Minneapolis, Minnesota), which uses a 980 nm diffusing tip diode laser. Cases were stratified into low, medium and high power. Maximal thermal damage estimate (TDEmax) achieved in a single plane and time to reach maximal damage (ttdemax) were measured and compared between groups using a 2×3 Fixed Factor Analysis of Covariance. Ablation area change for cases in which an initial thermal dose was followed by a subsequent dose, with increased power, was also assessed.Results: We used real-time ablation data from 93 patients across various intracranial pathologies. ttdemax (mean ± SEM) decreased linearly as power increased (low: 139.2 ± 10.4 s, medium: 127.5 ± 4.3 s, high: 103.7 ± 5.8 s). In cases where a second thermal dose was delivered at higher power, the TDE expanded an average of 51.4 mm2 beyond the initial TDE generated by the first ablation, with the second ablation approaching TDEmax at a higher rate than the initial ablation.Conclusion: Increased power results in a larger TDEmax and an increased ablation rate. In cases where an initial thermal dose does not fully ablate the target lesion, a second ablation at higher power can increase the area of ablation with an increased ablation rate.

A methodology for thermal dose model parameter development using perioperative MRI

Post-treatment imaging is the principal method for evaluating thermal lesions following image-guided thermal ablation procedures. While real-time temperature feedback using magnetic resonance temperature imaging (MRTI) is a complementary tool that can be used to optimise lesion size throughout the procedure, a thermal dose model is needed to convert temperature–time histories to estimates of thermal damage. However, existing models rely on empirical parameters derived from laboratory experiments that are not direct indicators of post-treatment radiologic appearance. In this work, we investigate a technique that uses perioperative MR data to find novel thermal dose model parameters that are tailored to the appearance of the thermal lesion on post-treatment contrast-enhanced imaging. Perioperative MR data were analysed for five patients receiving magnetic resonance-guided laser-induced thermal therapy (MRgLITT) for brain metastases. The characteristic enhancing ring was manually segmented on post-treatment T1-weighted imaging and registered into the MRTI geometry. Post-treatment appearance was modelled using a coupled Arrhenius-logistic model and non-linear optimisation techniques were used to find the maximum-likelihood kinetic parameters and dose thresholds that characterise the inner and outer boundary of the enhancing ring. The parameter values and thresholds were consistent with previous investigations, while the average difference between the predicted and segmented boundaries was on the order of one pixel (1 mm). The areas predicted using the optimised model parameters were also within 1 mm of those predicted by clinically utilised dose models. This technique makes clinically acquired data available for investigating new thermal dose model parameters driven by clinically relevant endpoints.

Lesion Optimization for Laser Ablation: Fluid Evacuation Prior to Laser-Induced Thermal Therapy

Magnetic resonance-guided laser-induced thermal therapy (MRgLITT) is a minimally invasive surgical procedure for ablating intracranial lesions. The presence of a fluid body can sequester thermal energy generated by the laser catheter, which compromises the performance of MRgLITT, resulting in suboptimal ablation of cystic lesions. We report our use of stereotactic fluid evacuation followed by MRgLITT in 2 patients with cystic brain tumors. This is the first report on lesion optimization by fluid aspiration before MRgLITT. Two cystic tumors in 2 patients were treated. In 1 patient, an external ventricular drain was placed stereotactically to allow drainage of cystic fluid 1 day before laser ablation. In the second patient, a stereotactic biopsy needle was used to aspirate the cystic fluid immediately before laser ablation. The remaining solid portions of the both tumors were ablated using the Visualase system. Both patients were followed clinically and radiologically after the procedures. Stereotactic placement of an external ventricular drain and a biopsy needle both successfully resulted in fluid evacuation. MRgLITT was performed without any complications in both patients after fluid evacuation. Both patients demonstrated clinical and radiologic improvement after the procedure. Cystic fluid evacuation is a promising strategy for optimizing intracranial cystic lesions for MRgLITT. This novel approach may broaden the utility of MRgLITT in the management of various technically demanding lesions.

Long-Term Follow-up of 25 Cases of Biopsy-Proven Radiation Necrosis or Post-Radiation Treatment Effect Treated With Magnetic Resonance-Guided Laser Interstitial Thermal Therapy.

Magnetic resonance-guided laser-induced thermal therapy (MRgLITT) is a minimally invasive surgical treatment for progressive neoplasms and post-radiation treatment effect (PRTE). To evaluate the radiographic response and efficacy of MRgLITT for biopsy-confirmed PRTE and the quality-of-life outcomes of patients following MRgLITT. We conducted a single-center retrospective study of radiographic responses and clinical outcomes of 25 patients with previously treated primary or secondary brain neoplasms (World Health Organization grades 4 [n = 8], 3 [n = 5], 2 [n = 5]) and metastatic brain tumors (n = 7). MRgLITT was applied directly following stereotactic needle biopsy confirming PRTE without any evidence of tumor presence. Mean overall survival times (months) for grades 4 and 3 and for metastatic brain tumors were 39.2 (standard error [SE], 7.6; 95% confidence interval [CI], 24.3-54.1), 29.1 (SE, 7.7; 95% CI, 14.0-44.2), and 55.9 (SE, 10.0; 95% CI, 36.3-75.4), respectively. Mean progression-free survival times after MRgLITT were 9.1 (SE, 3.6; 95% CI, 2.1-16.1), 8.5 (SE, 2.4; 95% CI, 3.9-13.2), and 11.4 (SE, 3.9; 95% CI, 3.8-19.0), respectively. Mean survival times after MRgLITT were 13.1 (SE, 2.3; 95% CI, 8.5-17.6), 12.2 (SE, 4.0; 95% CI, 4.4-20.0), and 19.2 (SE, 5.3; 95% CI, 8.9-29.6), respectively. The SF-36 indicated significant overall effects on mental health (P = .029) and vitality (P = .005). MRgLITT may be a viable option for patients with symptomatic advancing PRTE and is less invasive than open craniotomy. Although our results suggest a positive effect for MRgLITT on PRTE, prospective randomized trials with larger numbers of patients are needed to validate the study results. cRBV, relative cerebral blood volumeHIF1a, hypoxia-inducible factor 1aIMRT, intensity-modulated radiation therapyKPS, Karnofsky Performance StatusLITT, laser-induced thermal therapyMBT, metastatic brain tumorMRgLITT, magnetic resonance-guided laser-induced thermal therapyPRTE, post-radiation treatment effectSRS, stereotactic radiosurgeryVEGF, vascular endothelial growth factorWBXRT, whole brain radiation therapy.

Non-Invasive in vivo Loss Tangent Imaging: Thermal Sensitivity Estimation at the Larmor Frequency

Magnetic resonance imaging (MRI) is a versatile tool widely used for diagnosing disease. It provides high resolution anatomical information of the human with excellent soft tissue contrast, obtained in a non-invasive manner, and can be used to guide treatments and surgeries through monitoring of temperature and visualization of tumors (1-5). More recent applications related to hyperthermic therapy include magnetic resonance-guided laser-induced thermal therapy (3) and MR-guided focused ultrasound surgery (2), which demonstrated the possibility for application of MRI as a valuable tool in managing the ablation region. Hyperthermic ablation is a widely used therapeutic tool for cardiac arrhythmias and cancers of the liver, lung, kidney, and bone (6-9). RF and microwave ablation utilize the thermal sensitivity differences between tumor and normal tissue, which are primarily determined by the electrical properties (i.e., permittivity and conductivity). This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Received: March 11, 2016 Accepted: March 20, 2016

A model evaluation study for treatment planning of laser-induced thermal therapy

A cross-validation analysis evaluating computer model prediction accuracy for a priori planning magnetic resonance-guided laser-induced thermal therapy (MRgLITT) procedures in treating focal diseased brain tissue is presented. Two mathematical models are considered. (1) A spectral element discretisation of the transient Pennes bioheat transfer equation is implemented to predict the laser-induced heating in perfused tissue. (2) A closed-form algorithm for predicting the steady-state heat transfer from a linear superposition of analytic point source heating functions is also considered. Prediction accuracy is retrospectively evaluated via leave-one-out cross-validation (LOOCV). Modelling predictions are quantitatively evaluated in terms of a Dice similarity coefficient (DSC) between the simulated thermal dose and thermal dose information contained within N = 22 MR thermometry datasets. During LOOCV analysis, the transient model’s DSC mean and median are 0.7323 and 0.8001 respectively, with 15 of 22 DSC values exceeding the success criterion of DSC ≥ 0.7. The steady-state model’s DSC mean and median are 0.6431 and 0.6770 respectively, with 10 of 22 passing. A one-sample, one-sided Wilcoxon signed-rank test indicates that the transient finite element method model achieves the prediction success criteria, DSC ≥ 0.7, at a statistically significant level.

Accuracy of Laser Placement With Frameless Stereotaxy in Magnetic Resonance-Guided Laser-Induced Thermal Therapy.

As magnetic resonance-guided laser-induced thermal therapy (MRgLITT) becomes more accepted, there needs to be an evaluation of the techniques required to achieve accurate laser placement. To report our experience with frameless stereotaxy and the ability to achieve accurate laser placements. We also evaluate the variables associated with proper placement. We performed a retrospective analysis from 3 years of MRgLITT. Demographics and operational parameters, including trajectory length, target alignment error, registration error, and radial error were recorded and compared. Blinded review was used for completeness of ablation. In the study, 90 laser placements were evaluated for 72 cases. Trajectory length and target alignment error was 95.3 ± 26.0 mm and 0.7 ± 0.3 mm, respectively. Significant differences existed in registration error between 4 (0.6 ± 0.3 mm) and 5 (0.5 ± 0.2 mm) skull pins (P = .04), but no significant decreases in registration error as additional skull pins were registered. Fifteen laser placements resulted in subtotal ablations. The overall radial error using frameless stereotaxy was 0.9 ± 1.6 mm. In the study, 65% of lasers were exactly on the planned trajectory. Of the 30 that were not, the radial error = 2.6 ± 1.9 mm. Radial error of subtotal laser ablations was 0.5 ± 0.9 (range, 0-2.8 mm) and was not significantly different from 0.8 ± 1.7 (range, 0-7.1 mm) radial error of lasers with total ablations (P = .52). Lasers with radial error >0 mm resulted in an incomplete ablation in 26.7% of cases. Skull pin-based frameless stereotaxy for MRgLITT results in consistent accuracy, with the majority of cases resulting in complete ablations. A significant proportion of lasers with RE >0 mm still result in complete ablations.

Assessment of irrigation dynamics in magnetic-resonance guided laser induced thermal therapy (MRgLITT).

Magnetic-Resonance Guided Laser-Induced Thermal Therapy (MRgLITT) is a minimally-invasive ablation procedure for treating intracranial pathology using laser energy delivered through a fiber-optic. Saline irrigation is used to cool the fiber-optic, but factors affecting irrigation efficacy are not well studied, and quantitative information regarding irrigation speed and volume during MRgLITT procedures have not been reported. Here, we aimed to characterize variables affecting irrigation efficacy in MRgLITT. We investigated the irrigation setup of the Visualase thermal therapy system during MRgLITT procedures (Visualase Inc., Houston, TX). Using the system's peristaltic pump, irrigation flow rate was quantitated by measuring volume over five one-minute intervals. Pump settings 1-10 were assessed with and without the position-locking, resistance-imparting bone anchor in both single and double-catheter setups. Multiple tightness settings of the bone anchor were tested, and flow rates were analyzed. Rate of flow increased non-linearly with pump setting (F(1,4) = 2168.86; P < 0.001) in both single and double catheter setups. The lowest pump setting had a flow rate of 24 cc/min, while the highest setting was 36 cc/min. The rate of change in flow successively decreased without plateau. Tightness setting of the bone anchor affected flow in a reverse sigmoid pattern, with no impact on rate until after two quarter-turns, which produced a marked decrease in flow up to one-half of the initial rate (F(1,4) = 12818.96; P < 0.001). Flow rate through the cooling catheter in MRgLITT follows a non-linear pattern with increasing peristaltic pump speed. This rate is subject to significant changes when the bone anchor is tightened more than two quarter-turns. These findings serve as a foundation for future studies aimed at understanding the effect of irrigation speeds in achieving optimal ablation volumes.

NT-32 * TISSUE ABLATION DYNAMICS DURING MAGNETIC RESONANCE-GUIDED LASER INDUCED THERMAL THERAPY FOR INTRACRANIAL TUMORS

BACKGROUND: Magnetic Resonance-guided Laser Induced Thermal Therapy (MRgLITT) is a minimally-invasive procedure used in the treatment of intracranial tumors, epilepsy and pain. Thermal damage is estimated using real-time MR thermometry but little is known about the dynamics of the process and how various intracranial tumors affect overall ablation. OBJECTIVES: Determine the relationship between thermal energy delivery and the time to maximal estimated thermal damage in the setting of previously untreated glioblastoma multiforme (GBM), recurrent GBM, and metastatic tumors or radiation necrosis. We aim to understand whether differences exist between these intracranial malignancies and how the ablation process is affected. METHODS: We used real-time ablation data from 24 patients across five unique intracranial pathologies. Ablations were performed using the Visualase Thermal Therapy System (Visulase Inc.) using a 980-nm diffusing tip diode laser. Thermal damage area was plotted against time for each ablation. Subsequently, the duration required to reach 50% (t50) and 97% (t97) of maximum damage was estimated. Comparisons were then made between different intracranial pathologies. RESULTS: The average (mean ± SEM) t97 for previously untreated GBM (n = 7) recurrent GBM (n = 6) and tumor metastasis/radiation necrosis (n = 7) are 167 ± 18, 165 ± 22, 97 ± 22 seconds, respectively. The mean t97 is significantly shorter for tumor metastasis/radiation necrosis when compared with previously untreated GBM (p < 0.05). CONCLUSIONS: While optimal duration of thermal ablation varies between intracranial tumors, we found that metastatic tumor/radiation necrosis requires significantly shorter duration of ablation. In most cases, maximal ablation was reached long before the industry recommended ablation time. Understanding the duration required to reach maximal ablation may reduce thermal exposure times during the ablation process. Future studies are needed to examine the relationship between ablation power, irrigation speed, and the effect of prior therapies on the ablation dynamics.

SU‐E‐J‐161: Inverse Problems for Optical Parameters in Laser Induced Thermal Therapy

Purpose:Magnetic resonance‐guided laser‐induced thermal therapy (MRgLITT) is investigated as a neurosurgical intervention for oncological applications throughout the body by active post market studies. Real‐time MR temperature imaging is used to monitor ablative thermal delivery in the clinic. Additionally, brain MRgLITT could improve through effective planning for laser fiber's placement. Mathematical bioheat models have been extensively investigated but require reliable patient specific physical parameter data, e.g. optical parameters. This abstract applies an inverse problem algorithm to characterize optical parameter data obtained from previous MRgLITT interventions.Methods:The implemented inverse problem has three primary components: a parameter‐space search algorithm, a physics model, and training data. First, the parameter‐space search algorithm uses a gradient‐based quasi‐Newton method to optimize the effective optical attenuation coefficient, μ_eff. A parameter reduction reduces the amount of optical parameter‐space the algorithm must search. Second, the physics model is a simplified bioheat model for homogeneous tissue where closed‐form Green's functions represent the exact solution. Third, the training data was temperature imaging data from 23 MRgLITT oncological brain ablations (980 nm wavelength) from seven different patients.Results:To three significant figures, the descriptive statistics for μ_eff were 1470 m−1 mean, 1360 m−1 median, 369 m−1 standard deviation, 933 m−1 minimum and 2260 m−1 maximum. The standard deviation normalized by the mean was 25.0%. The inverse problem took &lt;30 minutes to optimize all 23 datasets.Conclusion:As expected, the inferred average is biased by underlying physics model. However, the standard deviation normalized by the mean is smaller than literature values and indicates an increased precision in the characterization of the optical parameters needed to plan MRgLITT procedures. This investigation demonstrates the potential for the optimization and validation of more sophisticated bioheat models that incorporate the uncertainty of the data into the predictions, e.g. stochastic finite element methods.

Magnetic Resonance-Guided Laser Ablation Improves Local Control for Postradiosurgery Recurrence and/or Radiation Necrosis

Enhancing lesions that progress after stereotactic radiosurgery are often tumor recurrence or radiation necrosis. Magnetic resonance-guided laser-induced thermal therapy (LITT) is currently being explored for minimally invasive treatment of intracranial neoplasms. To report the largest series to date of local control with LITT for the treatment of recurrent enhancing lesions after stereotactic radiosurgery for brain metastases. Patients with recurrent metastatic intracranial tumors or radiation necrosis who had previously undergone radiosurgery and had a Karnofsky performance status of >70 were eligible for LITT. Sixteen patients underwent a total of 17 procedures. The primary end point was local control using magnetic resonance imaging scans at intervals of >4 weeks. Radiographic outcomes were followed up prospectively until death or local recurrence (defined as >25% increase in volume compared with the 24-hour postprocedural scan). Fifteen patients (age, 46-82 years) were available for follow-up. Primary tumor histology was non-small-cell lung cancer (n = 12) and adenocarcinoma (n = 3). On average, the lesion size measured 3.66 cm (range, 0.46-25.45 cm); there were 3.3 ablations per treatment (range, 2-6), with 7.73-cm depth to target (range, 5.5-14.1 cm), ablation dose of 9.85 W (range, 8.2-12.0 W), and total ablation time of 7.43 minutes (range, 2-15 minutes). At a median follow-up of 24 weeks (range, 4-84 weeks), local control was 75.8% (13 of 15 lesions), median progression-free survival was 37 weeks, and overall survival was 57% (8 of 14 patients). Two patients experience recurrence at 6 and 18 weeks after the procedure. Five patients died of extracranial disease progression; 1 patient died of neurological progression elsewhere in the brain. Magnetic resonance imaging-guided LITT is a well-tolerated procedure and may be effective in treating tumor recurrence/radiation necrosis.

Design and initial evaluation of a treatment planning software system for MRI-guided laser ablation in the brain

An open-source software system for planning magnetic resonance (MR)-guided laser-induced thermal therapy (MRgLITT) in brain is presented. The system was designed to provide a streamlined and operator-friendly graphical user interface (GUI) for simulating and visualizing potential outcomes of various treatment scenarios to aid in decisions on treatment approach or feasibility. A portable software module was developed on the 3D Slicer platform, an open-source medical imaging and visualization framework. The module introduces an interactive GUI for investigating different laser positions and power settings as well as the influence of patient-specific tissue properties for quickly creating and evaluating custom treatment options. It also provides a common treatment planning interface for use by both open-source and commercial finite element solvers. In this study, an open-source finite element solver for Pennes' bioheat equation is interfaced to the module to provide rapid 3D estimates of the steady-state temperature distribution and potential tissue damage in the presence of patient-specific tissue boundary conditions identified on segmented MR images. The total time to initialize and simulate an MRgLITT procedure using the GUI was [Formula: see text]5 min. Each independent simulation took [Formula: see text]30 s, including the time to visualize the results fused with the planning MRI. For demonstration purposes, a simulated steady-state isotherm contour [Formula: see text] was correlated with MR temperature imaging (N = 5). The mean Hausdorff distance between simulated and actual contours was 2.0 mm [Formula: see text], whereas the mean Dice similarity coefficient was 0.93 [Formula: see text]. We have designed, implemented, and conducted initial feasibility evaluations of a software tool for intuitive and rapid planning of MRgLITT in brain. The retrospective in vivo dataset presented herein illustrates the feasibility and potential of incorporating fast, image-based bioheat predictions into an interactive virtual planning environment for such procedures.

SU-F-BRCD-08: Uncertainty Quantification by Generalized Polynomial Chaos for MR-Guided Laser Induced Thermal Therapy.

Magnetic resonance-guided laser induced thermal therapy (MRgLITT) is a minimally invasive thermal treatment for metastatic brain lesions, offering an alternative to conventional surgery. The purpose of this investigation is to incorporate uncertainty quantification (UQ) into the biothermal parameters used in the Pennes bioheat transfer equation (BHT), in order to account for imprecise values available in the literature. The BHT is a partial differential equation commonly used in thermal therapy models. MRgLITT was performed on an in vivo canine brain in a previous investigation. The canine MRgLITT was modeled using the BHT. The BHT has four parameters'" microperfusion, conductivity, optical absorption, and optical scattering'"which lack precise measurements in living brain and tumor. The uncertainties in the parameters were expressed as probability distribution functions derived from literature values. A univariate generalized polynomial chaos (gPC) expansion was applied to the stochastic BHT. The gPC approach to UQ provides a novel methodology to calculate spatio-temporal voxel-wise means and variances of the predicted temperature distributions. The performance of the gPC predictions were evaluated retrospectively by comparison with MR thermal imaging (MRTI) acquired during the MRgLITT procedure in the canine model. The comparison was evaluated with root mean square difference (RMSD), isotherm contours, spatial profiles, and z-tests. The peak RMSD was ∼1.5 standard deviations for microperfusion, conductivity, and optical absorption, while optical scattering was ∼2.2 standard deviations. Isotherm contours and spatial profiles of the simulation's predicted mean plus or minus two standard deviations demonstrate the MRTI temperature was enclosed by the model's isotherm confidence interval predictions. An a = 0.01 z-test demonstrates agreement. The application of gPC for UQ is a potentially powerful means for providing predictive simulations despite poorly known input parameters. gPC provides an output that represents the probable distribution of outcomes for MRgLITT.

Laser thermal therapy: Real‐time MRI‐guided and computer‐controlled procedures for metastatic brain tumors

We report the final results of a pilot clinical trial exploring the safety and feasibility of real-time magnetic resonance-guided laser-induced thermal therapy (MRgLITT) for treatment of resistant focal metastatic intracranial tumors. In patients with chemotherapy, whole-brain radiation, and radiosurgery resistant metastatic intracranial tumors, minimally invasive stereotaxic placement of a saline-cooled interstitial fiberoptic laser applicator under local anesthesia was followed by laser irradiation during continuous magnetic resonance imaging (MRI) scanning. A computer workstation extracted real-time temperature-sensitive information for feedback control over laser delivery. A total of 15 metastatic tumors were treated in 7 patients. Patients were followed with physical exam and imaging for 30 months. In all cases, the procedure was well tolerated, and patients were discharged home within 24 hours. Follow-up imaging at up to 30 months showed an acute increase in apparent lesion volume followed by a gradual and steady decrease. No tumor recurrence within thermal ablation zones was noted. Kaplan-Meier analysis indicated that the median survival was 19.8 months. Real-time magnetic resonance (MR) guidance of laser-induced thermal therapy (LITT) offers a high level of control. This tool therefore enables a minimally invasive option for destruction and treatment of resistant focal metastatic intracranial tumors. MR-guided LITT appears to provide a safe and potentially effective treatment for recurrent focal metastatic brain disease. A larger phase II and III series would be of interest to quantify potential median survival advantage.